GLP-1 agonists are a group of medications that help to manage blood sugar in people with Type 2 diabetes, some of which can be used to treat obesity even in people who do not have diabetes
Although the percentages of ALT responders and non-responders with dyslipidemia did not differ (80.0% vs
So with that study, the researchers involved in everything, did you spearhead the study or did they come to you
"We just need to monitor [these patients] closely, because there were some obstetric outcomes that we need to keep an eye on," she told Live Science
GLP1/E, at very low doses, is sufficient to ameliorate PCOS-associated metabolic alterations Since GLP1/E was superior to any other compound in terms of improvement of metabolic traits, we next assessed the metabolic efficacy of very low doses of this multi-agonist in our metabolically dysregulated PCOS model
Biochemistry 39, 59885994